Evidence map›Paper›PMID 30902391›Full record

ArticleBiochemical and biophysical research communications2019

High density lipoprotein promotes nascent apolipoprotein A-V secretion from mRNA transfected cells.

Irina Romenskaia, Christine M DeAntonis, Vladimir Presnyak, Joshua R Schultz, Robert O Ryan

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Irina RomenskaiaDepartment of Biochemistry and Molecular Biology, University of Nevada, Reno, NV, 89557, USA.
Christine M DeAntonisModerna, Inc., 200 Technology Square, Cambridge, MA, 02139, USA.
Vladimir PresnyakModerna, Inc., 200 Technology Square, Cambridge, MA, 02139, USA.
Joshua R SchultzModerna, Inc., 200 Technology Square, Cambridge, MA, 02139, USA.
Robert O RyanDepartment of Biochemistry and Molecular Biology, University of Nevada, Reno, NV, 89557, USA. Electronic address: robertryan@unr.edu.
Moderna Therapeutics (United States) · USUniversity of Nevada, Reno · US

Funding

Effect of Apolipoprotein Structural AdaptabilityR37HL064159 · NHLBI · UNIVERSITY OF NEVADA RENO · PI RYAN, ROBERT O'MARA · 2010 to 2019
$4.1M
NHLBI NIH HHS R37 HL064159
6 · The paper itself

Abstract

Despite its exceptionally low circulating concentration, apolipoprotein (apo) A-V is a potent modulator of plasma triacylglycerol levels. The secretion efficiency of nascent apoA-V was investigated in cultured cells transfected with mRNA. Following transfection of HepG2 cells with wild type apoA-V mRNA, apoA-V protein was detectable in cell lysates by 6 h. At 24 h post transfection, evidence of apoA-V secretion into media was obtained, although most apoA-V was recovered in the cell lysate fraction. By contrast, apoA-I was efficiently secreted into the culture medium. A positive correlation between culture medium fetal bovine serum content and the percentage of apoA-V recovered in conditioned media was observed. When transfected cells were cultured in serum-free media supplemented with increasing amounts of high density lipoprotein, a positive correlation with apoA-V secretion was observed. The data indicate that, following signal sequence cleavage, the bulk of nascent apoA-V remains cell associated. Transit of nascent apoA-V out of cultured cells is enhanced by the availability of extracellular lipid particle acceptors.

Indexed as

Apolipoprotein A-VBiological Transport, ActiveCulture MediaHEK293 CellsHep G2 CellsHumansLipoproteins, HDLRecombinant ProteinsRNA, MessengerTransfectionApolipoprotein A-VCulture MediaLipoproteins, HDLRecombinant ProteinsRNA, MessengerApolipoprotein a-vHEK293 cellsHepG2 cellsHigh density lipoproteinmRNA transfectionProtein secretion

Identifiers

PMID30902391
PMCPMC6467731
OpenAlexW2924933264

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.